Harvard Bioscience, Inc. (HBIO) NASDAQ

0.50

-0.0243(-4.59%)

Updated at August 18 04:00PM

Currency In USD

Valuation

Market Cap91.87M
Enterprise Value132.25M
P/E Ratio-0.39
PEG Ratio-0.26
Price/Sales Ratio0.26
Price/Book Ratio0
Enterprise/Revenue0.17
Enterprise/EBITDA-0.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.65
Operating Margin-0.47

Management Effectiveness

Return On Assets-0.72
Return On Equity-1.6

Income Statement

Revenue94.14M
Revenue/Share2
Gross Profit54.77M
EBITDA-1.47M
Net Income-12.41M
Diluted EPS-0.28

Balance Sheet

Total Cash7.44M
Total Cash/Share0.17
Total Debt43.31M
Total Debt/Equity0
Current Ratio0.81
Book Value Per Share1.81

Price History

52-Week Change-82.8
52-Week High3.27
52-Week Low0.28
Moving Average 50 Days0.49
Moving Average 200 Days1.1

Statistics

Average Volume12.09M
Shares Outstanding44.53M
% Held by Institutions42.68

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1319:1000
Last Split DateNovember 04, 2013